ELUT Q2 2024 Earnings — Elutia Inc. Revenue & Financial Results | Market Cap Arena

ELUTElutia Inc.

$48M

Q2 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$6M-0.9% YoY

Gross Profit

$3M44.5% margin

Operating Income

-$9M-135.3% margin

Net Income

-$28M-447.9% margin

EPS (Diluted)

$-1.13

QoQ Revenue Growth

-6.0%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$42M

Total Liabilities

$106M

Stockholders' Equity

-$64M

Cash & Equivalents

$18M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6M	$6M	-0.9%
Gross Profit	$3M	$3M	+3.1%
Operating Income	-$9M	-$6M	-34.9%
Net Income	-$28M	-$11M	-165.3%

Revenue Segments

Women's Health

$3M70%

Cardiovascular

$1M30%